Scarica l'app Stockscreener
13.37
2.38%
-0.295
Precedente Chiudi:
$13.66
Aprire:
$13.55
Volume 24 ore:
5,186
Relative Volume:
0.18
Capitalizzazione di mercato:
$27.53M
Reddito:
-
Utile/perdita netta:
$-4.85M
Rapporto P/E:
-43.13
EPS:
-0.31
Flusso di cassa netto:
$-3.95M
1 W Prestazione:
+1.83%
1M Prestazione:
-5.92%
6M Prestazione:
-18.91%
1 anno Prestazione:
-24.20%
Intervallo 1D:
$13.45
$13.63
Intervallo di 1 settimana:
$12.71
$13.75
Portata 52W:
$8.74
$22.90
Cadrenal Therapeutics Inc Stock (CVKD) Company Profile
Nome
Cadrenal Therapeutics Inc
Settore
Industria
Telefono
904-300-0701
Indirizzo
822 A1A NORTH, PONTE VEDRA
Confronta CVKD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CVKD
Cadrenal Therapeutics Inc
|
13.45 | 27.97M | 0 | -4.85M | -3.95M | -0.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
423.60 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
634.50 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.72 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.82 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.12 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Cadrenal Therapeutics Inc Stock (CVKD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-18 | Iniziato | Noble Capital Markets | Outperform |
Cadrenal Therapeutics Inc Borsa (CVKD) Ultime notizie
What the charts say about Cadrenal Therapeutics Inc. todayMarket Rally & Advanced Technical Signal Analysis - newser.com
Is Cadrenal Therapeutics Inc. stock cheap compared to fundamentals2025 Market Overview & Verified Swing Trading Watchlists - newser.com
Is Cadrenal Therapeutics Inc. trending in predictive chart modelsMarket Rally & Weekly Breakout Opportunity Watchlist - newser.com
Price momentum metrics for Cadrenal Therapeutics Inc. explainedMarket Sentiment Report & Long-Term Safe Investment Plans - newser.com
What to do if you’re stuck in Cadrenal Therapeutics Inc.2025 Bull vs Bear & Smart Money Movement Tracker - newser.com
Applying Elliott Wave Theory to Cadrenal Therapeutics Inc.Trade Exit Summary & Verified Entry Point Signals - newser.com
Quantitative breakdown of Cadrenal Therapeutics Inc. recent moveTrade Risk Summary & Safe Entry Momentum Tips - newser.com
Measuring Cadrenal Therapeutics Inc.’s beta against major indicesQuarterly Trade Report & Reliable Momentum Entry Alerts - newser.com
What institutional flow reveals about Cadrenal Therapeutics Inc.Trend Reversal & Stepwise Swing Trade Plans - newser.com
Cadrenal Therapeutics Inc Stock Analysis and ForecastEarnings Beat Highlights & The Best Picks Hiding in Plain Sight - earlytimes.in
Applying chart zones and confluence areas to Cadrenal Therapeutics Inc.Weekly Investment Recap & Fast Gain Stock Trading Tips - newser.com
Is Cadrenal Therapeutics Inc. stock a good choice for value investors2025 Volatility Report & Verified Entry Point Detection - newser.com
Kuick Research Releases Landmark Study On US Orphan Drug Rare Disease Market Highlighting Investment And Innovation Opportunities Through 2030 - Benzinga
Combining machine learning predictions for Cadrenal Therapeutics Inc.July 2025 Weekly Recap & Accurate Buy Signal Notifications - newser.com
Viridian Therapeutics (NASDAQ:VRDN) Director Acquires $9,999,990.00 in Stock - Defense World
Will Cadrenal Therapeutics Inc. see short term momentumQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
Why Cadrenal Therapeutics Inc. stock is rated strong buy2025 Earnings Impact & Fast Moving Trade Plans - newser.com
Insider Sell: Matthew Szot Sells Shares of Cadrenal Therapeutics Inc (CVKD) - GuruFocus
Cadrenal Therapeutics Executives Sell Shares - TradingView
CVKD CFO reports 3,600-share sale; 9,933 shares remain - Stock Titan
CVKD insider Quang Pham reports sales under Rule 10b5‑1 plan - Stock Titan
Can Cadrenal Therapeutics Inc. stock reach $100 price target2025 Trading Recap & Fast Entry Momentum Trade Alerts - fcp.pa.gov.br
History Review: Will Cadrenal Therapeutics Inc. stock outperform value stocksJuly 2025 Analyst Calls & Long-Term Capital Growth Ideas - Fundação Cultural do Pará
Aug Update: Can Cadrenal Therapeutics Inc. stock outperform in 2025 bull marketMarket Activity Summary & Weekly High Potential Stock Alerts - fcp.pa.gov.br
Cadrenal Therapeutics Inc Azioni (CVKD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.21%
0.74%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):